Medtronic plc (NYSE:MDT) Bernstein’s 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET
Company Participants
Geoff Martha – Chairman and Chief Executive Officer
Thierry Pieton – Executive Vice President and Chief Financial Officer
Conference Call Participants
Lee Hambright – Bernstein
Lee Hambright
All right. Very good. Well, thanks so much, guys. I’m Lee Hambright, Medtech Analyst at Bernstein. We’re very happy to host Medtronic today. We have CEO, Geoff Martha; and CFO, Thierry Pieton.
Just a reminder that investors can submit questions at any time through pigeonhole. We’ll try to work in as many as possible. Geoff is going to kick us off with a few opening remarks.
So, Geoff, please take it away.
Geoff Martha
All right. Thanks, everybody. Its working. Okay. Thanks, everybody, for being here today. I just thought I’d kick off first couple of minutes here, which just a quick overview here. I think these slides are available online and Ryan has got a QR code if you want them. These are our disclaimers or forward-looking statements. So please check these out.
Look, I’d start with just an overview of Medtronic. You can see here that, look, we’re organized around these three portfolios of businesses that are really — and then, of course, we have our diabetes business that we just made the announcement last week that we’ll be separating from and we’ll talk about — I’ll talk about that in a second.
But these three categories of business are defined, I’d say, think of it in three ways. One is scale, they’re all pretty big, $10 billion or so on average. But also they’re defined by — so they’ve got scale, but they’re also defined by category leadership. We’ve got lots of category leaders and franchises within those portfolios and technology differentiation. That’s what it’s all about, innovation-driven growth. We got a lot of technology differentiation
Read the full article here